Clinical Trials Sponsored by START Shanghai

Total 4987 results

Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients

Circulating Tumor DNA | Advanced NSCLC | Circulating Tumor Cells
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis

Bronchiectasis

China
Shenyang Northern Hospital
Changhai Hospital; ANKON medical technologies (Shanghai)Co.,LTD

Completed

Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation (OPT-PEACE)

Ischemic Heart Disease | Gastrointestinal Injury

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Augmented Reality Navigation Versus Traditional CT Guidance for Preoperative Localization of Pulmonary Nodules

Pulmonary Nodule

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Toripalimab Combined With SBRT for NSCLC

Non-small Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory Trial

Potentially Resectable ALK Positive Non-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial

Limited Stage Small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE)

Bronchiectasis Adult | Pseudomonas Aeruginosa Infection

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment

Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

The Efficacy and Safety of KN046 Combined With Axitinib

NSCLC

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Thymic Carcinoma

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Application of SERS Technology in Clinical Diagnosis and Prognosis of Lung Cancer Immunotherapy

Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Application of SERS Technology Based Intraoperative Navigation System in Lung Cancer

Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Lung Adenocarcinoma

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer | Locally Advanced

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis

Cystic Fibrosis, Pulmonary

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Clinical Characteristics of Lung Cancer in China

Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Assessment of an Exhaled Breath Test to Detect Bronchiectasis

Bronchiectasis

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

a Study of SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Application of Three-Dimensionally Printed Navigational Template in Lung Biopsy

Lung Neoplasms

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Neoadjuvant Durvalumab/Anlotinib /Chemotherapy Plus Curative Resection in Stage III Non-Small-Cell Lung Cancer : A Single-arm Phase II Study

Non Small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Stage III

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer

Small-cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Bronchoscopic Microwave Intervention Treatment in Advanced Central NSCLC

Safety Issues | Effect Increased
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Rapid and Accurate Detection of Major Mycobacterium Species in Pulmonary Infection Based on GenSeizer Platform

Mycobacterium Pulmonary Infection

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation

Non-Small Cell Lung Cancer | Chinese

China
Shanghai Pulmonary Hospital, Shanghai, China

Active, not recruiting

Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Stage III

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Idiopathic Bronchiectasis and Pulmonary Hypertension

Bronchiectasis | Pulmonary Hypertension

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Corticosteroid Treatment for Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Airway Clearance and Bronchoalveolar Lavage for Bronchiectasis Patients With Exacerbation

Bronchiectasis Adult

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients (CINSBDRILCP)

Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

NTM-LD Treatment Based on GenSeizer Characteristic Gene Capture Strategy

Non - Tuberculosis Mycobacteria Lung Disease

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis

Bronchiectasis | COPD

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis

Bronchiectasis

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis (VIDB)

Bronchiectasis

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP. (PAP)

Pulmonary Alveolar Proteinosis

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC (LungCadX)

NSCLC

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Airway Clearance Technique of Oscillation and Lung Expansion in Bronchiectasis

Bronchiectasis Adult

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer

Stage II-IIIB(N2) Non-small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Robot-assisted vs VATS for Thymoma

Thymoma

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma

EGFR Gene Mutation | Lung Adenocarcinoma Stage III | Lung Adenocarcinoma Stage IV

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial (MAGIC)

Multiple Primary Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer

Non-small Cell Lung Cancer | Advanced Lung Carcinoma
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients

Small-cell Lung Cancer | Neoadjuvant Therapy

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung Cancer

Small-cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation

Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

VATS VS. Open Thoracic Surgery for Stage II - III Lung Cancer (VOLCANO)

Lung Cancer | Surgery

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

Treatment | Histological Type of Neoplasm | Lung Adenocarcinoma, Stage I | Chemotherapy, Adjuvant

China
Shanghai Pulmonary Hospital, Shanghai, China

Terminated

Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer

Non Small Cell Lung Cancer

China

Clinical Trials Sponsored by START Shanghai

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations